198 related articles for article (PubMed ID: 24626475)
1. Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer.
Thériault BL; Basavarajappa HD; Lim H; Pajovic S; Gallie BL; Corson TW
PLoS One; 2014; 9(3):e91540. PubMed ID: 24626475
[TBL] [Abstract][Full Text] [Related]
2. Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.
Thériault BL; Pajovic S; Bernardini MQ; Shaw PA; Gallie BL
Int J Cancer; 2012 Apr; 130(8):1844-54. PubMed ID: 21618518
[TBL] [Abstract][Full Text] [Related]
3. The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cells.
Thériault BL; Cybulska P; Shaw PA; Gallie BL; Bernardini MQ
J Ovarian Res; 2014 Dec; 7():123. PubMed ID: 25528264
[TBL] [Abstract][Full Text] [Related]
4. KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer.
Wang ZZ; Yang J; Jiang BH; Di JB; Gao P; Peng L; Su XQ
Int J Oncol; 2018 Nov; 53(5):1939-1952. PubMed ID: 30226594
[TBL] [Abstract][Full Text] [Related]
5. The motor protein KIF14 inhibits tumor growth and cancer metastasis in lung adenocarcinoma.
Hung PF; Hong TM; Hsu YC; Chen HY; Chang YL; Wu CT; Chang GC; Jou YS; Pan SH; Yang PC
PLoS One; 2013; 8(4):e61664. PubMed ID: 23626713
[TBL] [Abstract][Full Text] [Related]
6. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer.
Yang Z; Li C; Yan C; Li J; Yan M; Liu B; Zhu Z; Wu Y; Gu Q
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):181-192. PubMed ID: 30404039
[TBL] [Abstract][Full Text] [Related]
7. KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer.
Corson TW; Zhu CQ; Lau SK; Shepherd FA; Tsao MS; Gallie BL
Clin Cancer Res; 2007 Jun; 13(11):3229-34. PubMed ID: 17545527
[TBL] [Abstract][Full Text] [Related]
8. High expression of KIF14 is associated with poor prognosis in patients with epithelial ovarian cancer.
Qiu HL; Deng SZ; Li C; Tian ZN; Song XQ; Yao GD; Geng JS
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(2):239-245. PubMed ID: 28165566
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA PAXIP1-AS1 facilitates cell invasion and angiogenesis of glioma by recruiting transcription factor ETS1 to upregulate KIF14 expression.
Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Yu H; Qi L
J Exp Clin Cancer Res; 2019 Dec; 38(1):486. PubMed ID: 31823805
[TBL] [Abstract][Full Text] [Related]
10. KIF14 mRNA expression is a predictor of grade and outcome in breast cancer.
Corson TW; Gallie BL
Int J Cancer; 2006 Sep; 119(5):1088-94. PubMed ID: 16570270
[TBL] [Abstract][Full Text] [Related]
11. RNA interference-mediated silencing of mitotic kinesin KIF14 disrupts cell cycle progression and induces cytokinesis failure.
Carleton M; Mao M; Biery M; Warrener P; Kim S; Buser C; Marshall CG; Fernandes C; Annis J; Linsley PS
Mol Cell Biol; 2006 May; 26(10):3853-63. PubMed ID: 16648480
[TBL] [Abstract][Full Text] [Related]
12. Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients.
Wang Q; Wang L; Li D; Deng J; Zhao Z; He S; Zhang Y; Tu Y
Cancer Epidemiol; 2013 Feb; 37(1):79-84. PubMed ID: 22999822
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-152 specifically targets kinesin family member 14 to suppress the advancement of bladder cancer cells via PI3K/AKT pathway.
Meng F; Zhang Z
Biochem Biophys Res Commun; 2024 Jan; 692():149337. PubMed ID: 38070277
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of KIF14 Suppresses Tumor Cell Growth and Promotes Apoptosis in Human Glioblastoma.
Huang W; Wang J; Zhang D; Chen W; Hou L; Wu X; Lu Y
Cell Physiol Biochem; 2015; 37(5):1659-70. PubMed ID: 26536004
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer.
Zhang Y; Yuan Y; Liang P; Zhang Z; Guo X; Xia L; Zhao Y; Shu XS; Sun S; Ying Y; Cheng Y
Oncotarget; 2017 Jul; 8(28):45459-45469. PubMed ID: 28525372
[TBL] [Abstract][Full Text] [Related]
16. KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers.
Corson TW; Huang A; Tsao MS; Gallie BL
Oncogene; 2005 Jul; 24(30):4741-53. PubMed ID: 15897902
[TBL] [Abstract][Full Text] [Related]
17. KIF14 and E2F3 mRNA expression in human retinoblastoma and its phenotype association.
Madhavan J; Mitra M; Mallikarjuna K; Pranav O; Srinivasan R; Nagpal A; Venkatesan P; Kumaramanickavel G
Mol Vis; 2009; 15():235-40. PubMed ID: 19190782
[TBL] [Abstract][Full Text] [Related]
18. KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer.
Singel SM; Cornelius C; Zaganjor E; Batten K; Sarode VR; Buckley DL; Peng Y; John GB; Li HC; Sadeghi N; Wright WE; Lum L; Corson TW; Shay JW
Neoplasia; 2014 Mar; 16(3):247-56, 256.e2. PubMed ID: 24784001
[TBL] [Abstract][Full Text] [Related]
19. The kinesin KIF14 is overexpressed in medulloblastoma and downregulation of KIF14 suppressed tumor proliferation and induced apoptosis.
Li KK; Qi Y; Xia T; Chan AK; Zhang ZY; Aibaidula A; Zhang R; Zhou L; Yao Y; Ng HK
Lab Invest; 2017 Aug; 97(8):946-961. PubMed ID: 28504687
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation.
Gopisetty G; Xu J; Sampath D; Colman H; Puduvalli VK
Oncogene; 2013 Jun; 32(26):3119-29. PubMed ID: 22945648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
